Garrouste-Orgeas, Maité
Azoulay, Elie
Ruckly, Stéphane
Schwebel, Carole
de Montmollin, Etienne
Bedos, Jean-Pierre
Souweine, Bertrand
Marcotte, Guillaume
Adrie, Christophe
Goldgran-Toledano, Dany
Dumenil, Anne-Sylvie
Kallel, Hatem
Jamali, Samir
Argaud, Laurent
Darmon, Michael
Zahar, Jean-Ralph
Timsit, J. F.
Funding for this research was provided by:
Pfizer France
Article History
Received: 25 November 2017
Accepted: 22 June 2018
First Online: 4 July 2018
Compliance with ethical standards
:
: MGO: shares in ICUREsearch. JFT: scientific board: ICUREsearch, Bayer, Merk, Paratek, 3M, Gilead. Lectures for Gilead, Pfizer, Merck, Astellas. Grants from Pfizer, 3M, Merck, Astellas. EA: is part of the board of Gilead Sciences. He has received fees for lecture from Gilead, Astellas, MSD, Alexion and Baxter. His institution has received research support from Glead, Pfizer, Fisher & Payckle, Jazz pharma, Alexion and Basilea. SR, JRZ: shares in ICUREsearch, JPB: scientific board Pfizer, Lectures Pfizer, MSD. No conflict of interests: LA, GM, CS, EdM, JPB, BS, CA, DGT, ASD, HK, SJ, MD.